Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naïve individuals in a tertiary care hospital in Beijing, China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naïve individuals in a tertiary care hospital in Beijing, China

Published:2019-10-01 Issue:12 Volume:33 Page:1945-1947
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Liu Lifeng,Dai Lili,Yao Jun,Pan Pinliang,Li Li,Liu Zhiying,An Xizhao,Sun Lijun,Wu Hao,Su Bin,Zhang Tong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference17 articles.

1. HIV prevalence in China: integration of surveillance data and a systematic review;Zhang;Lancet Infect Dis,2013

2. HIV integrase inhibitors: a new era in the treatment of HIV;Blanco;Expert Opin Pharmacother,2015

3. Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance;Brenner;Virus Res,2017

4. HIV drug resistance against strand transfer integrase inhibitors;Anstett;Retrovirology,2017

5. Integrase-resistant HIV in an antiretroviral-naive patient in Australia;Rafiei;AIDS,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023;The Journal of Infectious Diseases;2024-08-27

2. Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China;Chinese Medical Journal;2023-11-03

3. Increased prevalence of pretreatment drug resistance mutations in treatment-naïve people living with HIV-1 in Henan Province, China (2022/23);Infection, Genetics and Evolution;2023-11

4. Identification of integrase inhibitor-related drug resistance mutations in newly diagnosed ART-naïve HIV patients;Microbial Pathogenesis;2023-08

5. Prevalence of HIV Transmitted Drug Resistance in Nanjing from 2018 to 2021;Infection and Drug Resistance;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3